| FIDELITY FUNDS-ASIA EQUITY ESG A-ACC-EUR | RVI ASIA EX-JAPÓN | 48,05% | 56,06% | 28,99% | 142,25% |
| SCHRODER ISF EMERGING ASIA A DIS GBP | RVI ASIA PACÍFICO | 48,05% | 59,78% | 29,48% | 147,46% |
| ALLIANZ EMERGING MARKETS EQUITY SRI A EUR | RVI EMERGENTES | 48,04% | 78,53% | · | · |
| M&G (LUX) JAPAN FUND EUR A ACC | RVI JAPÓN | 48,04% | 69,15% | 93,68% | 194,70% |
| ALLIANZ JAPAN EQUITY AT (H-EUR) EUR | RVI JAPÓN | 48,01% | 95,22% | 132,71% | 256,98% |
| LAZARD EMERGING MARKETS EQUITY B ACC USD | RVI EMERGENTES | 48,01% | 97,95% | 93,90% | · |
| BGF EMERGING MARKETS C2 EUR | RVI EMERGENTES | 47,99% | 49,12% | 10,13% | 97,82% |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 47,99% | 21,48% | -21,92% | · |
| JPM FUNDS-EMERGING MARKETS EQUITY PLUS D (ACC) EUR | RVI EMERGENTES | 47,98% | 81,76% | 54,06% | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 47,97% | 21,88% | -21,63% | · |
